HIV immunogenic complexes comprising GP120 covalently bound to CD4 or concanavalin A
US6465172B1 · kind B1 · utility
5Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 17, 2001 |
| Grant date | Oct 15, 2002 |
| Priority date | — |
| Expiry date | Jul 17, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/975
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A vaccine and a method of raising neutralizing antibodies against HIV infection. The vaccine comprises a complex of gp120 covalently bonded to CD4 or to succinyl concanavalin A. Also disclosed are immunological tests using the complex or antibody thereto for detection of HIV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.